PRIME-RT: durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC): a randomised phase II trial
Roxburgh, C. S. ; Hanna, C. R. ; Saunders, M. P. ; Arthur, C. ; Samuel, L. M. ; Wells, L. ; Muirhead, R. ; MacLeod, N. J. ; Graham, J. S. ; Devlin, L. ... show 10 more
Roxburgh, C. S.
Hanna, C. R.
Saunders, M. P.
Arthur, C.
Samuel, L. M.
Wells, L.
Muirhead, R.
MacLeod, N. J.
Graham, J. S.
Devlin, L.
Citations
Altmetric:
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Roxburgh CS, Hanna CR, Saunders MP, Arthur C, Samuel LM, Wells L, et al. PRIME-RT: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC): a randomised phase II trial. RADIOTHERAPY AND ONCOLOGY. 2025 MAY;206:S1163-S4. PubMed PMID: WOS:001517479600044. English.